PENTASA® (Asacol, Mesalazine) - is used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease.
GUARANTEE & EXPIRY DATE
100% original from German pharmaceutical company Ferring GmbH.
All packs are air tight sealed and expire up to 06.2027.
Photos of the product are for illustation purpose only and may vary according to the manufacturer.
Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis: https://www.dovepress.com/long-term-efficacy-and-safety-of-once-daily-mesalazine-granules-for-th-peer-reviewed-fulltext-article-CEG
PENTASA® comes in the form of tablets for oral use: 500 mg per tablet, 50 tablets per pack.
Mesalazine - 500 mg.
Microcrystalline cellulose 207 mg, povidone 25 mg, talc 9 mg, ethyl cellulose 6-9 mg, magnesium stearate 1 mg.
Orally, after food, with water, without chewing.
Acute period: 2 tablets 2-4 times a day.
Maintenance therapy: 1 tablet 2-3 times a day.
Acute period: 2 to 4 tablets 4 times a day.
Maintenance therapy: 2-4 tablets 2 times a day or 2-3 tablets 3 times a day.
The dose is selected individually, usually 20-30 mg of mesalazine per 1 kg of body weight per day in several doses.
Side effects are primarily gastrointestinal but may also include headache GI effects include nausea, diarrhea and abdominal pain.
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about PENTASA.
|The purpose of the medication||Liver and Gastrointestinal Treatment|